[Randomised phase II study evaluating oral combination chemotherapy (CCNU, cyclophosphamide, etoposide) and intravenous chemotherapy as second-line treatment for relapsed small cell bronchial carcinoma (Trial GFPC0501)].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples